Related Experiment Videos
Human vault-associated non-coding RNAs bind to mitoxantrone, a chemotherapeutic compound
Subash C B Gopinath1, Akimasa Matsugami, Masato Katahira
1Functional Nucleic Acids Group, Institute for Biological Resources and Functions, National Institute of Advanced Industrial Science and Technology 1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan.
Nucleic Acids Research
|September 10, 2005
Summary
Human vault RNAs (vRNAs) bind to the chemotherapy drug mitoxantrone. This interaction suggests vRNAs may help vaults export toxic compounds from cancer cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Human vaults are large cytoplasmic ribonucleoprotein complexes.
- Vaults are overexpressed in cancer cells and implicated in xenobiotic extrusion.
- Direct observation of xenobiotic interactions with vault components is lacking.
Purpose of the Study:
- To investigate the direct binding of xenobiotics to vault RNAs (vRNAs).
- To identify the specific vRNAs and binding regions involved in xenobiotic interaction.
- To explore the functional implications of vRNA-xenobiotic interactions in cellular context.
Main Methods:
- In-line probing assay to map RNA-ligand interactions.
- In vitro translation inhibition assay to study interactions in a cellular milieu.
- Identification of specific vault RNA (vRNA) sequences (hvg-1, hvg-2).
Main Results:
- Vault RNAs (vRNAs), specifically hvg-1 and hvg-2, directly bind to the chemotherapeutic agent mitoxantrone.
- The mitoxantrone binding region within vRNAs was identified using in-line probing.
- vRNA-mitoxantrone interactions were observed in a cellular context via translation inhibition assays.
Conclusions:
- vRNAs possess the ability to bind specific chemotherapeutic compounds like mitoxantrone.
- These interactions suggest a role for vRNAs in the vault-mediated export of toxic substances.
- Findings provide direct evidence for vRNA involvement in vault function and xenobiotic transport.